Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
latest_posts
- 1
21 Things You Ought to Never Tell Your Childless Companion - 2South African radio presenter among five charged over Russia recruitment plot
- 3Gulf countries continue to face Iran attacks as criticial energy infrastructure at risk
- 4Inflammatory Merz remarks on migrants' violence against women slammed
- 5Africa's energy giants eye long-term gains on Iran war disruption
- Savvy Watches: Which One Is Appropriate for You?
- Factbox-Artemis II crew includes first woman, Black astronaut and Canadian ever flown to moon
- Extraordinary Guinness World Records That Will Astound You
- Support Your Investment funds with These Individual accounting Thoughts
- Rick Steves Prefers Paying A Bit Extra For This Delectable Food When Dining In Spain
- Change Your Home into an Exercise center with These Famous Wellness Gadgets
- Moscow: Russia well-positioned to withstand oil market shocks
- The most effective method to Help a Friend or family member Determined to have Cellular breakdown in the lungs
- Home Wellness Basics: Building Your Home Exercise center
